Sequencing Antibody Drug Conjugates in ER+/HER2 LOW MBC
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer|Advanced Breast Cancer|Hormone-receptor-positive Breast Cancer|Human Epidermal Growth Factor 2 Low Breast Cancer
Interventions: DRUG: Sacituzumab govitecan
Sponsor: Reshma L. Mahtani, D.O.
Collaborators: Gilead Sciences